← All companies

CELG

Bristol-Myers Squibb Company Ce

CELG-RI NYSE Pharmaceutical Preparations EDGAR ↗

$0.11

+0.01 +12.77%

Key statistics

from XBRL data in SEC filings

Market cap

$217M

Revenue (TTM)

$49.2B

Net income (TTM)

$9.28B

EPS (TTM)

$4.55

P/E ratio

0.0

Dividend yield

2367.92%

Free cash flow

$12.8B

Cash

$8.72B

Total assets

$87.6B

Gross margin

62.5%

52-week range

$0.09 – $0.12

Recent SEC filings

40 most recent

Annual, quarterly & current reports

10-Q Quarter ended 2026-06-30 Jul 30, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jul 30, 2026 8-K Shareholder vote results May 8, 2026 10-Q Quarter ended 2026-03-31 Apr 30, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Apr 30, 2026 10-K Fiscal year ended 2025-12-31 Feb 11, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Feb 5, 2026 8-K Regulation FD disclosure Jan 12, 2026 8-K Other events Nov 18, 2025 8-K Other events Nov 10, 2025 8-K Other events Nov 3, 2025 10-Q Quarter ended 2025-09-30 Oct 30, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Oct 30, 2025 10-Q Quarter ended 2025-06-30 Jul 31, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Jul 31, 2025 8-K Director or officer change Jul 25, 2025 8-K Shareholder vote results May 7, 2025 10-Q Quarter ended 2025-03-31 Apr 24, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Apr 24, 2025 8-K Director or officer change Feb 18, 2025 10-K Fiscal year ended 2024-12-31 Feb 12, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Feb 6, 2025 8-K Regulation FD disclosure Jan 13, 2025 10-Q Quarter ended 2024-09-30 Oct 31, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Oct 31, 2024 10-Q Quarter ended 2024-06-30 Jul 26, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Jul 26, 2024 8-K Director or officer change Jun 18, 2024 8-K Amended charter or bylaws; Shareholder vote results May 9, 2024 10-Q Quarter ended 2024-03-31 Apr 25, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Apr 25, 2024 8-K Director or officer change Mar 18, 2024 8-K Other events Mar 18, 2024 8-K Other events Feb 22, 2024 8-K Director or officer change Feb 15, 2024 8-K Other events Feb 14, 2024 10-K Fiscal year ended 2023-12-31 Feb 13, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Feb 2, 2024 8-K Regulation FD disclosure Jan 8, 2024 8-K Other events Dec 22, 2023